لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Amato VS; Universidade de São Paulo, Faculdade de Medicina, Departamento de Doenças e Moléstias Infecciosas, São Paulo, São Paulo, 05403-000, Brazil., Ribeiro VST; Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, 80215-901, Brazil. Electronic address: victoria.ribeiro@pucpr.edu.br., Silva AG; Instituto Suel Abujamra, setor de Retina e Vítreo, São Paulo, São Paulo, 01525-001, Brazil., Gomes AMV; Instituto Suel Abujamra, setor de Retina e Vítreo, São Paulo, São Paulo, 01525-001, Brazil., Tuon FF; Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, 80215-901, Brazil.

المصدر: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2024 Jul; Vol. 109 (3), pp. 116266. Date of Electronic Publication: 2024 Mar 15.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0070 (Electronic) Linking ISSN: 07328893 NLM ISO Abbreviation: Diagn Microbiol Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Pyrimethamine*/therapeutic use , Pyrimethamine*/adverse effects , Toxoplasmosis, Ocular*/drug therapy , Sulfonamides*/therapeutic use , Sulfonamides*/adverse effects , Clindamycin*/therapeutic use, Humans ; Female ; Adult ; Recurrence ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use ; Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects ; Drug Hypersensitivity/etiology ; Brazil ; Antiprotozoal Agents/therapeutic use ; Antiprotozoal Agents/adverse effects ; Treatment Outcome ; Prednisone/therapeutic use

المؤلفون: Amato VS; Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Parasitologia, São Paulo, Brazil.; Universidade de São Paulo, Faculdade de Medicina, Departamento de Doenças e Moléstias Infecciosas, São Paulo, Brazil., Franco LAM; Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Parasitologia, São Paulo, Brazil., de Souza RM; Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Parasitologia, São Paulo, Brazil., da Silva CAM; Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Parasitologia, São Paulo, Brazil., Ramundo MS; Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Parasitologia, São Paulo, Brazil., Côrtes MF; Universidade de São Paulo, Instituto de Medicina Tropical de São Paulo, Laboratório de Bacteriologia e Resistência Antimicrobiana, São Paulo, Brazil., Corrêa-Castro G; Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.; Núcleo de Ciências Biomédicas Aplicadas, Instituto Federal de Educação, Ciência e Tecnologia - IFRJ, Rio de Janeiro, Brazil., Santos-Oliveira JR; Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.; Núcleo de Ciências Biomédicas Aplicadas, Instituto Federal de Educação, Ciência e Tecnologia - IFRJ, Rio de Janeiro, Brazil., Da-Cruz AM; Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil., Pagliari C; Departamento de Patologia, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil., Galo LK; Departamento de Patologia, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil., Tuon FF; Pontifícia Universidade Católica do Paraná, Laboratório de Doenças Infecciosas e Emergentes, Curitiba, Brazil.

المصدر: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2023 Dec 18; Vol. 110 (2), pp. 228-233. Date of Electronic Publication: 2023 Dec 18 (Print Publication: 2024).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: American Society of Tropical Medicine and Hygiene Country of Publication: United States NLM ID: 0370507 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1476-1645 (Electronic) Linking ISSN: 00029637 NLM ISO Abbreviation: Am J Trop Med Hyg Subsets: MEDLINE

مواضيع طبية MeSH: Leishmaniasis, Mucocutaneous*/diagnosis , Leishmaniasis, Mucocutaneous*/drug therapy , Leishmania* , HIV Infections*/complications, Humans ; CD4 Lymphocyte Count ; Immunity

المؤلفون: Lyra MR; Laboratory of Clinical Research and Surveillance in Leishmaniasis, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Oliveira LFA; Laboratory of Clinical Research and Surveillance in Leishmaniasis, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Schubach AO; Laboratory of Clinical Research and Surveillance in Leishmaniasis, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Sampaio RNR; Dermatology Service of Internal Medicine, Faculty of Medicine of the University of Brasília, Brasília, DF, Brazil., Rodrigues BC; Dermatology Service of Internal Medicine, Faculty of Medicine of the University of Brasília, Brasília, DF, Brazil., Hueb M; Internal Medicine Department, Julio Muller University Hospital, Federal University of Mato Grosso, Cuiabá, Mato Grosso, Brazil., Cota G; Clinical Research and Public Policies in Infectious Diseases, René Rachou Institute, Fiocruz Minas, Belo Horizonte, MG, Brazil., Silva RE; Clinical Research and Public Policies in Infectious Diseases, René Rachou Institute, Fiocruz Minas, Belo Horizonte, MG, Brazil., Francesconi F; Dermatology Department, Heitor Vieira Dourado Tropical Medicine Foundation, Manaus, AM, Brazil.; Dermatology Department, Federal University of Amazonas, Manaus, AM, Brazil., Pompilio MA; Faculty of Medicine of the Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil., França AO; Faculty of Medicine of the Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil., Amato VS; Laboratory of Parasitology, Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo, Brazil., Souza RM; Laboratory of Parasitology, Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo, Brazil., Oliveira RVC; Laboratory of Clinical Epidemiology, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Valete CM; Laboratory of Clinical Research and Surveillance in Leishmaniasis, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Department of Otorhinolaryngology and Ophthalmology, Faculty of Medicine of Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Pimentel MIF; Laboratory of Clinical Research and Surveillance in Leishmaniasis, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Aug 22; Vol. 77 (4), pp. 574-582.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antiprotozoal Agents*/adverse effects , Organometallic Compounds*/adverse effects , Leishmaniasis, Cutaneous*/drug therapy, Humans ; Meglumine Antimoniate/therapeutic use ; Meglumine Antimoniate/adverse effects ; Meglumine/adverse effects ; Brazil ; Treatment Outcome

المؤلفون: Tuon FF; Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifical Catholic University of Paraná, Rua Imaculada Conceição 1155, Curitiba, Paraná 80215-901, Brazil., Amato VS; Departamento de Doenças Infecciosas e Parasitária da Faculdade de Medicina da Universidade de São Paulo São Paulo, Av. Dr Arnaldo 455, São Paulo 05403-000, Brazil., Zequinao T; Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifical Catholic University of Paraná, Rua Imaculada Conceição 1155, Curitiba, Paraná 80215-901, Brazil., Cruz JAW; School of Business, Pontifical Catholic University of Paraná, Rua Imaculada Conceição 1155, Curitiba, Paraná 80215-901, Brazil.; Fundação Getúlio Vargas, EAESP, São Paulo, Av. 9 de Julho 2029, São Paulo 013013-902, Brazil.

المصدر: Transactions of the Royal Society of Tropical Medicine and Hygiene [Trans R Soc Trop Med Hyg] 2022 Nov 01; Vol. 116 (11), pp. 981-985.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7506129 Publication Model: Print Cited Medium: Internet ISSN: 1878-3503 (Electronic) Linking ISSN: 00359203 NLM ISO Abbreviation: Trans R Soc Trop Med Hyg Subsets: MEDLINE

مواضيع طبية MeSH: Tropical Medicine* , Leishmaniasis*/diagnosis , Leishmaniasis*/drug therapy, Humans ; Neglected Diseases/drug therapy ; Neglected Diseases/epidemiology ; Neglected Diseases/diagnosis ; Income ; Morbidity